OFFICE OF THE
DIRECTOR
The Office of the Director includes eight offices within the State Hygienic Laboratory that provide specialized organizational services across the laboratory. These offices are: Genomics, Human Resources, Information and Technology, Iowa Laboratory Appraisal Program-CLIA, Organizational Development, Public Policy, Research and Development, and Strategic Communications.

Research and Development

The Office of Research and Development oversees internal and external efforts to advance the research capabilities of the lab. Internally, the office provides guidance on research projects in the areas of molecular science and genomics, including potential interface with environmental influences on human health and development. Additionally, the office evaluates and advises the director of the Hygienic Laboratory on activities, including test methods, instrumentation and the overall science platform of the laboratory. Externally, the office advises and assists in the development of research agreements with external partners.

Hygienic Laboratory scientists are involved in numerous studies and projects that utilize advanced resources and apply them to tests and processes. This is known as translational or applied research. The goal of this research is to perform practical studies that can be used to improve the health of Iowans within a short implementation timeframe.

The Hygienic Laboratory has a history of participation in applied research activities. For example, staff scientists have developed or modified analytical procedures for measuring toxic compounds or pathogens in air, water, food and clinical samples. They provide advice and collaborate with researchers at the University of Iowa on a variety of topics, including infectious diseases, environmental health, occupational health, birth defects and neonatal health.

Engagement in research is one of the core functions of a Public Health Laboratory.

Major achievements:

  • Developed an assay to screen for Severe Combined Immunodeficiency syndrome (SCID). Starting July 1, 2014, SCID screening results were officially reported as part of the Iowa newborn screening panel, which tests nearly 40,000 babies every year.
  • Collaborated with University of Iowa Hospitals and Clinics on a study aimed to identify children with immune system defects other than SCID and used the information from the SCID screening to determine the degree of risk of infection for these children.
  • Through a collaboration with UIHC’s Dr. Ben Darbro, SCID screening data is compared to whole exome sequencing data generated by next generation sequencing. A grant from the Children’s Miracle Network provides resources to collect 22q11 del gene sequences, which may identify genes that cause specific defects in children. This information could be used to possibly diagnose children with 22q11 del earlier and begin treatment more quickly. Loss of a part of the 22nd chromosome – 22q11 deletion syndrome (22q11 del) – is the most common genetic defect, occurring in approximately one in every 3,000 births. Children diagnosed with this disorder may have several developmental problems that include immune system defects.
  • Collaborated with UI College of Public Health faculty member Matt Nonnenmann, Ph.D., to detect influenza virus in hospitals.